JP2000262298A - 全血中のグルコース濃度もしくはコレステロール濃度の定量方法 - Google Patents

全血中のグルコース濃度もしくはコレステロール濃度の定量方法

Info

Publication number
JP2000262298A
JP2000262298A JP11068589A JP6858999A JP2000262298A JP 2000262298 A JP2000262298 A JP 2000262298A JP 11068589 A JP11068589 A JP 11068589A JP 6858999 A JP6858999 A JP 6858999A JP 2000262298 A JP2000262298 A JP 2000262298A
Authority
JP
Japan
Prior art keywords
concentration
whole blood
cholesterol
glucose
hematocrit value
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP11068589A
Other languages
English (en)
Japanese (ja)
Inventor
Toshihiro Mori
寿弘 森
Takayoshi Arai
貴喜 新井
Yoshikazu Amano
芳和 天野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Holdings Corp
Original Assignee
Fuji Photo Film Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Photo Film Co Ltd filed Critical Fuji Photo Film Co Ltd
Priority to JP11068589A priority Critical patent/JP2000262298A/ja
Priority to EP00104594A priority patent/EP1037048A3/de
Publication of JP2000262298A publication Critical patent/JP2000262298A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP11068589A 1999-03-15 1999-03-15 全血中のグルコース濃度もしくはコレステロール濃度の定量方法 Withdrawn JP2000262298A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP11068589A JP2000262298A (ja) 1999-03-15 1999-03-15 全血中のグルコース濃度もしくはコレステロール濃度の定量方法
EP00104594A EP1037048A3 (de) 1999-03-15 2000-03-15 Quantitative Analyse von Glucose oder Cholesterin in Vollblut

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11068589A JP2000262298A (ja) 1999-03-15 1999-03-15 全血中のグルコース濃度もしくはコレステロール濃度の定量方法

Publications (1)

Publication Number Publication Date
JP2000262298A true JP2000262298A (ja) 2000-09-26

Family

ID=13378146

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11068589A Withdrawn JP2000262298A (ja) 1999-03-15 1999-03-15 全血中のグルコース濃度もしくはコレステロール濃度の定量方法

Country Status (2)

Country Link
EP (1) EP1037048A3 (de)
JP (1) JP2000262298A (de)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003294746A (ja) * 2002-01-31 2003-10-15 Fuji Photo Film Co Ltd 生化学解析用ユニットの製造方法
JP2005046145A (ja) * 2003-07-17 2005-02-24 Ortho Clinical Diagnostics Inc 高比重リポタンパク質コレステロール定量化のための乾式分析要素
JP2006081492A (ja) * 2004-09-17 2006-03-30 Chiba Univ コレステロールの定量方法
WO2007007849A1 (ja) 2005-07-14 2007-01-18 Matsushita Electric Industrial Co., Ltd. 分析装置、及び分析方法
WO2009119213A1 (ja) 2008-03-25 2009-10-01 テルモ株式会社 ヘマトクリット値または血液成分濃度の測定方法および測定装置
JP2010522336A (ja) * 2007-03-22 2010-07-01 クオシェント ダイアグノスティックス リミテッド 全血分析
WO2010140407A1 (ja) * 2009-06-05 2010-12-09 テルモ株式会社 成分測定装置
WO2013147200A1 (ja) * 2012-03-29 2013-10-03 積水メディカル株式会社 ヘマトクリット値の測定方法
WO2020183916A1 (ja) * 2019-03-11 2020-09-17 テルモ株式会社 血糖値算出プログラム、血糖値算出方法及び血糖値測定装置

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7476533B2 (en) 2002-04-19 2009-01-13 Adhesives Research, Inc. Diagnostic devices for use in the assaying of biological fluids
AU2003234944A1 (en) * 2002-08-27 2004-03-18 Bayer Healthcare, Llc Methods of Determining Glucose Concentration in Whole Blood Samples
EP1447665B1 (de) 2003-02-11 2016-06-29 Bayer HealthCare LLC Methode zur Verringerung des Einflusses von Hämatokrit auf die Analytbestimmung in Vollblut
EP1875203B1 (de) * 2004-12-13 2011-05-04 Bayer HealthCare LLC Transmissionspektroskopiesystem zur verwendung bei der bestimmung von analyten in körperflüssigkeit
US20060281187A1 (en) 2005-06-13 2006-12-14 Rosedale Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
US8801631B2 (en) 2005-09-30 2014-08-12 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
JP5232003B2 (ja) 2005-09-30 2013-07-10 インテュイティ メディカル インコーポレイテッド 多部分体液試料採取及び分析カートリッジ
WO2009145920A1 (en) 2008-05-30 2009-12-03 Intuity Medical, Inc. Body fluid sampling device -- sampling site interface
US10383556B2 (en) 2008-06-06 2019-08-20 Intuity Medical, Inc. Medical diagnostic devices and methods
JP5642066B2 (ja) 2008-06-06 2014-12-17 インテュイティ メディカル インコーポレイテッド 体液の試料内に含まれている検体の存在または濃度を決定する検定を行う方法および装置
EP3106871B1 (de) 2009-11-30 2021-10-27 Intuity Medical, Inc. Verfahren zum verifizieren der genauigkeit des betriebs einer analyt-überwachungsvorrichtung
EP3750480B1 (de) 2011-08-03 2022-02-02 Intuity Medical, Inc. Vorrichtung zur entnahme von körperflüssigkeiten
FR3005505B1 (fr) * 2013-05-13 2015-05-01 Biomerieux Sa Procede de mesure de la concentration plasmatique d'un analyte directement sur un echantillon de sang total
JP6521948B2 (ja) 2013-06-10 2019-05-29 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 体液中の分析物を検出するための方法およびシステム
JP6757400B2 (ja) * 2016-03-08 2020-09-16 テルモ株式会社 成分測定装置、成分測定方法及び成分測定プログラム

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57174099A (en) * 1981-04-17 1982-10-26 Fuji Photo Film Co Ltd Color indicator composition for detecting hydrogen peroxide and quantitative analytical film having reagent layer containing the same
US4627014A (en) * 1984-04-09 1986-12-02 Eastman Kodak Company Method and apparatus for determination of an analyte and method of calibrating such apparatus
US4935346A (en) * 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
DE68927777T2 (de) * 1988-06-09 1997-06-12 Boehringer Mannheim Corp Testvorrichtung mit definiertem Volumen
US5126275A (en) * 1990-09-19 1992-06-30 Miles Inc. Analytical method using tetrazolium salt indicators having a reflectance plateau
DE69227545T2 (de) * 1991-07-12 1999-04-29 Robinson, Mark R., Albuquerque, N.Mex. Oximeter zur zuverlässigen klinischen Bestimmung der Blutsauerstoffsättigung in einem Fötus

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003294746A (ja) * 2002-01-31 2003-10-15 Fuji Photo Film Co Ltd 生化学解析用ユニットの製造方法
JP2005046145A (ja) * 2003-07-17 2005-02-24 Ortho Clinical Diagnostics Inc 高比重リポタンパク質コレステロール定量化のための乾式分析要素
JP2006081492A (ja) * 2004-09-17 2006-03-30 Chiba Univ コレステロールの定量方法
WO2007007849A1 (ja) 2005-07-14 2007-01-18 Matsushita Electric Industrial Co., Ltd. 分析装置、及び分析方法
JP2010522336A (ja) * 2007-03-22 2010-07-01 クオシェント ダイアグノスティックス リミテッド 全血分析
JP2009236487A (ja) * 2008-03-25 2009-10-15 Terumo Corp ヘマトクリット値または血液成分濃度の測定方法および測定装置
WO2009119213A1 (ja) 2008-03-25 2009-10-01 テルモ株式会社 ヘマトクリット値または血液成分濃度の測定方法および測定装置
WO2010140407A1 (ja) * 2009-06-05 2010-12-09 テルモ株式会社 成分測定装置
JP2010281751A (ja) * 2009-06-05 2010-12-16 Terumo Corp 成分測定装置
WO2013147200A1 (ja) * 2012-03-29 2013-10-03 積水メディカル株式会社 ヘマトクリット値の測定方法
JPWO2013147200A1 (ja) * 2012-03-29 2015-12-14 積水メディカル株式会社 ヘマトクリット値の測定方法
WO2020183916A1 (ja) * 2019-03-11 2020-09-17 テルモ株式会社 血糖値算出プログラム、血糖値算出方法及び血糖値測定装置
JPWO2020183916A1 (de) * 2019-03-11 2020-09-17
JP7372310B2 (ja) 2019-03-11 2023-10-31 テルモ株式会社 血糖値算出プログラム、血糖値算出方法及び血糖値測定装置

Also Published As

Publication number Publication date
EP1037048A2 (de) 2000-09-20
EP1037048A3 (de) 2000-12-20

Similar Documents

Publication Publication Date Title
EP1037048A2 (de) Quantitative Analyse von Glucose oder Cholesterin in Vollblut
CN1143132C (zh) 可用肉眼观察的血糖检测条
JPH0234600B2 (de)
JP2864035B2 (ja) 全血分析要素
JPH0726959B2 (ja) 全血分析要素
JP2000175699A (ja) 一体型多層化学分析要素および測定方法
JPH0550275B2 (de)
JPH0721455B2 (ja) 液体試料中の特定成分を分析するための用具および方法
JPH0726960B2 (ja) 乾式全血分析要素
US5063153A (en) Integral multilayer analytical element
JPH0623759B2 (ja) 全血分析要素
JPH02208565A (ja) 血液から血漿を分離する方法、器具、およびこれを用いる分析要素
JPS63163164A (ja) 多層分析素子
USH600H (en) Whole blood analytical element and method of analyzing whole blood using the same
JP2565788B2 (ja) 高比重リポ蛋白コレステロールの定量方法
JPH01101453A (ja) 被分析物質の検出方法
JP4879185B2 (ja) 膜のコーティング方法
JPS63109799A (ja) 乾式コレステロ−ル分析要素
JP2000035427A (ja) 乾式分析要素の製造方法及び乾式分析要素
KR20060132689A (ko) 다층 분석 요소
JP2000258414A (ja) 一体型多層化学分析要素および定量方法
JP3779048B2 (ja) コリンエステラーゼ定量用乾式分析素子
JP2000146960A (ja) 一体型多層化学分析要素および測定方法
JPH01262470A (ja) 乾式全血分析要素
JPS6394993A (ja) 酸化型補酵素を含有する乾式分析要素

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20060606